Pilot study of daily ifosfamide 1 g/m2 until grade III granulocytopenia as second-line chemotherapy for anthracycline-pretreated advanced soft tissue sarcoma

Tumori

Volumn 84, Issue 6, 1998, Pages 677-680

  Babovic, N ^a   Jelic, S ^a   Milanovic, N ^a   Matkovic, S ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Ifosfamide; Second line chemotherapy; Soft tissue sarcoma

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CISPLATIN; EPIRUBICIN; IFOSFAMIDE; MESNA; ZORUBICIN;

ADULT; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GRANULOCYTOPENIA; HALLUCINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; SOFT TISSUE SARCOMA; THROMBOCYTOPENIA;

EID: 0032466901     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169808400613     Document Type: Article

References (24)